Orchid Pharma share news and announcements
NSE: ORCHPHARMABSE: 524372Pharmaceuticals & BiotechnologySmall Cap
Formerly Orchid Chemicals & Pharmaceuticals
Last close ₹823.30down ₹52.25 (5.97%)BSE ₹826.10
Share price at the NSE close on 23 Oct 2026. Previous close ₹875.55.
52-week range of traded prices to 23 Oct 2026
₹480.00Low, 30 Mar 2026₹1,143.50High, 22 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,930 Cr919th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 0.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Aug 2026
- 0.19
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,70,48053.5% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Orchid Pharma quarterly results
Aug14Fri
The board met on 14 Aug 2026 to consider financial results
Notice filed 11 Aug 2026
Orchid Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Orchid Pharma financials, year by year
Annual reports7
- Annual report, year to Mar 2026 (opens in a new tab)8 Sep 2026
- Annual report, year to Mar 2025 (opens in a new tab)26 Aug 2025
- Annual report, year to Mar 2024 (opens in a new tab)27 Jul 2024
- Annual report, year to Mar 2023 (opens in a new tab)18 Jul 2023, a zip file
- Annual report, year to Mar 2022 (opens in a new tab)22 Jun 2022, a zip file
2 earlier reports
- Annual report, year to Mar 2021 (opens in a new tab)22 Jul 2021, a zip file
- Annual report, year to Mar 2020 (opens in a new tab)31 Dec 2020, a zip file
Investor presentations24
- Presentation (opens in a new tab)20 Aug 2026
- Investor Presentation (opens in a new tab)26 May 2026
- Presentation (opens in a new tab)11 Feb 2026
- Investor Presentation (opens in a new tab)11 Nov 2025
- Investor Presentation (opens in a new tab)12 Aug 2025
19 earlier presentations
- Investor Presentation (opens in a new tab)26 May 2025
- Presentation (opens in a new tab)12 Feb 2025
- Investor Presentation (opens in a new tab)11 Nov 2024
- Presentation (opens in a new tab)13 Aug 2024
- Presentation (opens in a new tab)23 May 2024
- Investor Presentation (opens in a new tab)8 Feb 2024
- Investor Presentation (opens in a new tab)20 Nov 2023
- Presentation (opens in a new tab)6 Nov 2023
- Investor Presentation (opens in a new tab)14 Aug 2023
- Investor Presentation (opens in a new tab)11 May 2023
- Investor Presentation (opens in a new tab)17 Feb 2023
- Investor Presentation (opens in a new tab)18 Nov 2022
- Investor Presentation (opens in a new tab)18 Nov 2022
- Investors Presentation on Un-Audited Standalone & Consolidated Financial Results for the Quarter Ended 30 June, 2022 (opens in a new tab)10 Aug 2022
- Investor Presentation (opens in a new tab)23 Dec 2021
- Investor Presentation (opens in a new tab)23 Nov 2021
- Investor Presentation (opens in a new tab)16 Jun 2021
- Investor Presentation (opens in a new tab)9 Jun 2021
- Investor Presentation (opens in a new tab)9 Jun 2021
Earnings calls34
- Transcript (opens in a new tab)24 Aug 2026
- Link of Recording (opens in a new tab)21 Aug 2026
- Transcript (opens in a new tab)1 Jun 2026
- Link of Recording (opens in a new tab)26 May 2026
- Transcript (opens in a new tab)16 Feb 2026
29 earlier call documents
- Link of Recording (opens in a new tab)12 Feb 2026
- Transcript (opens in a new tab)17 Nov 2025
- Link of Recording (opens in a new tab)11 Nov 2025
- Transcript (opens in a new tab)14 Aug 2025
- Link of Recording (opens in a new tab)12 Aug 2025
- Transcript (opens in a new tab)2 Jun 2025
- Link of Recording (opens in a new tab)26 May 2025
- Transcript (opens in a new tab)15 Feb 2025
- Link of Recording (opens in a new tab)12 Feb 2025
- Transcript (opens in a new tab)15 Nov 2024
- Link of Recording (opens in a new tab)11 Nov 2024
- Transcript (opens in a new tab)17 Aug 2024
- Link of Recording (opens in a new tab)13 Aug 2024
- Transcript (opens in a new tab)29 May 2024
- Link of Recording (opens in a new tab)24 May 2024
- Transcript (opens in a new tab)13 Feb 2024
- Link of Recording (opens in a new tab)9 Feb 2024
- Transcript (opens in a new tab)10 Nov 2023
- Link of Recording (opens in a new tab)6 Nov 2023
- Transcript (opens in a new tab)21 Aug 2023
- Link of Recording (opens in a new tab)14 Aug 2023
- Announcement under regulation 30 of SEBI (LODR) Regulations, 2015 - Transcript of Investor Call (opens in a new tab)18 May 2023
- Link of Recording (opens in a new tab)11 May 2023
- Transcript (opens in a new tab)22 Feb 2023
- Link of Recording (opens in a new tab)17 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)23 Nov 2022
- Audio Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)18 Nov 2022
- Transcript of Analysts/Investors Conference Call pertaining to the Financial Results for the Quarter ended June 30, 2022 (opens in a new tab)17 Aug 2022
- Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the Quarter ended June 30, 2022 (opens in a new tab)10 Aug 2022
Orchid Pharma share news and announcements
858 announcements, routine notices left out, newest first. Page 1 of 18.
Oct 2026
20 Oct · Board meeting
15 Oct · Board meeting
Sep 2026
3 Sep · Board meeting
Aug 2026
17 Aug · Analysts
1 Aug · Board meeting
Jul 2026
25 Jul · Updates
10 Jul · Amendment to AOA/MOA
7 Jul · Business
Jun 2026
11 Jun · Legal
May 2026
19 May · Analysts
Apr 2026
11 Apr · Legal
2 Apr · Rating
Mar 2026
18 Mar · Updates
Feb 2026
11 Feb · Board meeting
6 Feb · Analysts
Nov 2025
5 Nov · Analysts
4 Nov · Legal
The exchange asked on 3 Nov 2025
Oct 2025
30 Oct · General Updates
Sep 2025
How the price met the news
The latest 30. The first session after each announcement, beside the market. Moves to 8 Jan 2018 are on BSE closes, before the company traded on NSE.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 17 Aug 2026Resultsdown 4.52%−4.4 pts vs Nifty 500market median −0.7% · five sessions −4.2% (−3.9 pts vs Nifty 500) · volume 2.8× usual · delivery −3.1 pts against usual · The announcement (opens in a new tab)
- 26 May 2026Resultsup 1.26%+1.4 pts vs Nifty 500market median −0.7% · five sessions +15.3% (+17.1 pts vs Nifty 500) · volume 1.5× usual · delivery −21.3 pts against usual · The announcement (opens in a new tab)
- 6 Apr 2026Credit ratingup 1.19%0.0 pts vs Nifty 500market median 0.0% · five sessions +6.7% (−0.1 pts vs Nifty 500) · volume 0.4× usual · delivery −13.0 pts against usual · The announcement (opens in a new tab)
- 12 Feb 2026Resultsdown 2.55%−2.0 pts vs Nifty 500market median −0.7% · five sessions −3.7% (−3.1 pts vs Nifty 500) · volume 4.2× usual · delivery +21.4 pts against usual · The announcement (opens in a new tab)
- 11 Nov 2025Resultsdown 2.65%−3.0 pts vs Nifty 500market median −0.7% · five sessions +1.7% (+0.2 pts vs Nifty 500) · volume 0.8× usual · delivery −6.0 pts against usual · The announcement (opens in a new tab)
- 13 Aug 2025Resultsup 1.19%+0.6 pts vs Nifty 500market median −0.7% · five sessions −0.2% (−2.7 pts vs Nifty 500) · volume 1.3× usual · delivery −19.4 pts against usual · The announcement (opens in a new tab)
- 8 Aug 2025Credit ratingdown 0.46%+0.6 pts vs Nifty 500market median 0.0% · five sessions −1.3% (−1.3 pts vs Nifty 500) · volume 0.9× usual · delivery −17.9 pts against usual · The announcement (opens in a new tab)
- 1 Jul 2025Board or managers changedup 3.53%+3.5 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+3.7 pts vs Nifty 500) · volume 1.7× usual · delivery −0.7 pts against usual · The announcement (opens in a new tab)
- 7 Mar 2025Credit ratingup 4.82%+4.8 pts vs Nifty 500market median 0.0% · five sessions −14.4% (−13.0 pts vs Nifty 500) · volume 0.6× usual · delivery +2.7 pts against usual · The announcement (opens in a new tab)
- 15 Apr 2024Board or managers changedup 0.92%+2.2 pts vs Nifty 500market median 0.0% · five sessions −3.3% (−2.4 pts vs Nifty 500) · volume 2.3× usual · delivery −51.0 pts against usual · The announcement (opens in a new tab)
20 earlier announcements
- 15 Dec 2023Credit ratingup 7.33%+6.4 pts vs Nifty 500market median 0.0% · five sessions +10.0% (+10.2 pts vs Nifty 500) · volume 3.5× usual · delivery +7.1 pts against usual · The announcement (opens in a new tab)
- 14 Dec 2023Board or managers changeddown 0.06%−1.2 pts vs Nifty 500market median 0.0% · five sessions +5.6% (+5.4 pts vs Nifty 500) · volume 0.3× usual · delivery −9.8 pts against usual · The announcement (opens in a new tab)
- 1 Dec 2023Credit ratingup 3.67%+3.0 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−4.4 pts vs Nifty 500) · volume 1.6× usual · delivery −6.7 pts against usual · The announcement (opens in a new tab)
- 10 Feb 2023Credit ratingup 3.50%+3.6 pts vs Nifty 500market median 0.0% · five sessions +7.4% (+7.1 pts vs Nifty 500) · volume 3.6× usual · The announcement (opens in a new tab)
- 2 Feb 2023Board or managers changeddown 2.47%−2.4 pts vs Nifty 500market median 0.0% · five sessions +12.5% (+11.3 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 26 Dec 2022Credit ratingup 4.01%+2.3 pts vs Nifty 500market median 0.0% · five sessions +1.1% (−1.6 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 11 Aug 2022Resultsdown 1.02%−1.8 pts vs Nifty 500market median −0.7% · five sessions −0.1% (−2.9 pts vs Nifty 500) · volume 1.0× usual · The announcement (opens in a new tab)
- 22 Jul 2022Board or managers changeddown 2.88%−3.3 pts vs Nifty 500market median 0.0% · five sessions −7.0% (−8.4 pts vs Nifty 500) · volume 11.6× usual · The announcement (opens in a new tab)
- 27 Dec 2021Credit ratingdown 0.30%−0.7 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−1.9 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 30 Sep 2021Credit ratingdown 1.15%−0.9 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−0.6 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
- 8 Jan 2018Board or managers changedup 4.93%+4.2 pts vs Nifty 500market median 0.0% · five sessions +4.7% (+3.8 pts vs Nifty 500) · volume 0.6× usual · The announcement (opens in a new tab)
- 18 Apr 2017Credit ratingup 5.33%+5.8 pts vs Nifty 500market median 0.0% · five sessions +6.3% (+5.2 pts vs Nifty 500) · volume 5.9× usual · The announcement (opens in a new tab)
- 8 Jun 2016Board or managers changedup 4.60%+4.3 pts vs Nifty 500market median 0.0% · five sessions +8.4% (+9.7 pts vs Nifty 500) · volume 3.4× usual · The announcement (opens in a new tab)
- 29 Nov 2012Board or managers changedup 1.28%−0.2 pts vs Nifty 500market median 0.0% · five sessions +5.2% (+1.9 pts vs Nifty 500) · volume 1.3× usual
- 14 May 2012Dividenddown 13.35%−12.8 pts vs Nifty 500market median 0.0% · five sessions −20.6% (−19.6 pts vs Nifty 500) · volume 5.3× usual
- 18 May 2011Dividenddown 4.59%−4.1 pts vs Nifty 500market median 0.0% · five sessions −10.7% (−9.6 pts vs Nifty 500) · volume 3.8× usual
- 20 Oct 2010Board or managers changeddown 0.07%+0.5 pts vs Nifty 500market median 0.0% · five sessions +12.2% (+11.1 pts vs Nifty 500) · volume 0.4× usual
- 28 May 2010Dividendup 4.71%+3.2 pts vs Nifty 500market median 0.0% · five sessions +7.5% (+4.4 pts vs Nifty 500) · volume 2.5× usual
- 31 Mar 2010Board or managers changeddown 1.50%−1.5 pts vs Nifty 500market median 0.0% · five sessions +3.1% (+0.5 pts vs Nifty 500) · volume 0.4× usual
- 30 Jun 2009Dividenddown 5.59%−3.2 pts vs Nifty 500market median 0.0% · five sessions −11.2% (−6.1 pts vs Nifty 500) · volume 0.8× usual
Orchid Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.
Figures filed again
The latest 30. Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Net profit | Year to date to Mar 2026 | Consolidated | 20.55 | 9.96 | −51.5% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Profit before one-off items and tax | Year to Mar 2026 | Consolidated | 27.59 | 17.76 | −35.6% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Total expenses | Year to date to Mar 2026 | Consolidated | 818.91 | 1,251.44 | +52.8% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Profit before tax | Quarter to Mar 2026 | Consolidated | 22.79 | 24.85 | +9.0% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Earnings per share, continuing businesses | Year to Mar 2026 | Consolidated | 4.05 | 1.66 | −59.0% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Profit before one-off items and tax | Quarter to Mar 2026 | Consolidated | 22.25 | 25.07 | +12.7% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Other expenses | Year to Mar 2026 | Consolidated | 152.85 | 237.09 | +55.1% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Total expenses | Quarter to Mar 2026 | Consolidated | 222.70 | 351.03 | +57.6% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Profit before tax | Year to Mar 2026 | Consolidated | 21.02 | 10.43 | −50.4% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |
| Net profit | Year to Mar 2026 | Consolidated | 20.55 | 9.96 | −51.5% | 25 May 2026 (opens in a new tab) | 14 Aug 2026 (opens in a new tab) |